The purpose of the study is to test a new treatment protocol for wet macular degeneration, called Observe and Plan, against today's standard protocol Treat and Extend. Studies suggest that the individual treatment interval can be achieved earlier with Observe-and-Plan and that a proportion of patients do not need more than 3 injections, ie the loading dose. The other advantages seem to be that patients achieve good visual acuity with fewer controls and are more satisfied with the new protocol, which will be beneficial to both patients and health care. To our knowledge, no randomized controlled trial has tested this before.
The purpose of this study is to compare two different treatment protocols for wet macular degeneration; the new protocol called Observe and Plan against the current standard protocol Treat and Extend. Studies suggest that patients achieve equally good visual acuity with fewer controls and that they are more satisfied with the new protocol.